Myriad Genetics, Inc.
US ˙ NasdaqGS ˙ US62855J1043

SecurityMYGN / Myriad Genetics, Inc.
InstitutionEngineers Gate Manager LP
Latest Disclosed Ownership114,799 shares
Latest Disclosed Value $ 516,596
Engineers Gate Manager LP reports 77.87% increase in ownership of MYGN / Myriad Genetics, Inc.

On May 15, 2026 - Engineers Gate Manager LP filed a 13F-HR form disclosing ownership of 114,799 shares of Myriad Genetics, Inc. (US:MYGN) valued at $516,596 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 64,542 shares of Myriad Genetics, Inc.. This represents a change in shares of 77.87% during the quarter. The current value of the position is $505,116 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F MYRIAD GENETICS COM 62855J104 114,799 50,257 77.87 517 30.30 0.0065
2026-02-17 2025-12-31 13F MYRIAD GENETICS COM 62855J104 64,542 -34,706 -34.97 397 -44.77 0.0047
2025-11-14 2025-09-30 13F MYRIAD GENETICS COM 62855J104 99,248 20,421 25.91 718 71.53 0.0082
2025-08-14 2025-06-30 13F MYRIAD GENETICS COM 62855J104 78,827 -13,779 -14.88 419 -49.09 0.0052
2025-05-15 2025-03-31 13F MYRIAD GENETICS COM 62855J104 92,606 -9,908 -9.67 821 -41.57 0.0138
2025-02-14 2024-12-31 13F MYRIAD GENETICS COM 62855J104 102,514 67,670 194.21 1,405 47.27 0.0245
2024-11-14 2024-09-30 13F MYRIAD GENETICS COM 62855J104 34,844 10,714 44.40 954 61.69 0.0186
2024-08-14 2024-06-30 13F MYRIAD GENETICS COM 62855J104 24,130 24,130 590 0.0133
2024-05-15 2024-03-31 13F MYRIAD GENETICS COM 62855J104 0 -45,146 -100.00 0 -100.00
2024-02-14 2023-12-31 13F MYRIAD GENETICS COM 62855J104 45,146 26,471 141.75 864 188.96 0.0247
2023-11-14 2023-09-30 13F MYRIAD GENETICS COM 62855J104 18,675 4,734 33.96 300 -7.43 0.0111
2023-08-14 2023-06-30 13F MYRIAD GENETICS COM 62855J104 13,941 13,941 323 0.0122
2023-02-14 2022-12-31 13F MYRIAD GENETICS COM 62855J104 0 -26,093 -100.00 0 -100.00
2022-11-14 2022-09-30 13F MYRIAD GENETICS COM 62855J104 26,093 -124,735 -82.70 498 -81.83 0.0310
2022-08-15 2022-06-30 13F MYRIAD GENETICS COM 62855J104 150,828 136,554 956.66 2,741 661.39 0.1005
2022-05-16 2022-03-31 13F MYRIAD GENETICS COM 62855J104 14,274 14,274 360 0.0141
2022-02-14 2021-12-31 13F MYRIAD GENETICS COM 62855J104 0 -48,153 -100.00 0 -100.00
2021-11-15 2021-09-30 13F MYRIAD GENETICS COM 62855J104 48,153 48,153 1,555 0.0886
2021-02-16 2020-12-31 13F MYRIAD GENETICS COM 62855J104 0 -93,912 -100.00 0 -100.00
2020-11-16 2020-09-30 13F MYRIAD GENETICS COM 62855J104 93,912 -126,010 -57.30 1,225 -50.88 0.0575
2020-08-17 2020-06-30 13F MYRIAD GENETICS COM 62855J104 219,922 219,922 2,494 0.1269
2020-05-15 2020-03-31 13F MYRIAD GENETICS COM 62855J104 0 -100,953 -100.00 0 -100.00
2020-02-14 2019-12-31 13F MYRIAD GENETICS COM 62855J104 100,953 100,953 2,749 0.1209
2019-11-14 2019-09-30 13F MYRIAD GENETICS COM 62855J104 0 -120,290 -100.00 0 -100.00
2019-08-14 2019-06-30 13F MYRIAD GENETICS COM 62855J104 120,290 32,450 36.94 3,341 14.57 0.1844
2019-05-15 2019-03-31 13F MYRIAD GENETICS COM 62855J104 87,840 87,840 2,916 0.1766
2018-05-07 2018-03-31 13F MYRIAD GENETICS COM 62855J104 0 -21,533 -100.00 0 -100.00
2018-02-01 2017-12-31 13F MYRIAD GENETICS COM 62855J104 21,533 21,533 740 0.0508
2017-11-13 2017-09-30 13F MYRIAD GENETICS COM 62855J104 0 -56,841 -100.00 0 -100.00
2017-08-10 2017-06-30 13F MYRIAD GENETICS COM 62855J104 56,841 23,491 70.44 1,469 129.53 0.1324
2017-05-05 2017-03-31 13F MYRIAD GENETICS COM 62855J104 33,350 33,350 640 0.0635
2016-11-09 2016-09-30 13F MYRIAD GENETICS COM 62855J104 0 -63,100 -100.00 0 -100.00
2016-08-11 2016-06-30 13F MYRIAD GENETICS COM 62855J104 63,100 63,100 0.00 1,931 0.1386
2016-05-09 2016-03-31 13F MYRIAD GENETICS COM 62855J104 0 -10,951 -100.00 0 -100.00
2016-02-05 2015-12-31 13F MYRIAD GENETICS COM 62855J104 10,951 10,951 473 0.0319
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.